Title:
PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING ATOPIC DISEASE CONTAINING FAECALIBACTERIUM PRAUSNITZII STRAIN
Document Type and Number:
WIPO Patent Application WO/2022/045502
Kind Code:
A1
Abstract:
The present invention relates to a pharmaceutical composition effective for the prevention or treatment of atopic disease, the pharmaceutical composition containing a Faecalibacterium prausnitzii EB-FPDK11 strain or a culture or dried product thereof. While traditional probiotics generally have an insignificant therapeutic effect for atopic disease, the pharmaceutical composition of the present invention exhibits a preventive or therapeutic effect on atopic disease at the same level as that of steroid-based drugs, and thus is not only promising as pharmabiotics, but also useful in the development of food and cosmetics.
Inventors:
SEO JAE-GU (KR)
SHIN JOO-HYUN (KR)
LEE DOKYUNG (KR)
LEE YOONMI (KR)
JANG SEO YUL (KR)
BYEON HYE RIM (KR)
SHIN JOO-HYUN (KR)
LEE DOKYUNG (KR)
LEE YOONMI (KR)
JANG SEO YUL (KR)
BYEON HYE RIM (KR)
Application Number:
PCT/KR2021/002433
Publication Date:
March 03, 2022
Filing Date:
February 26, 2021
Export Citation:
Assignee:
ENTEROBIOME INC (KR)
International Classes:
A61K35/74; A23L33/135; A61K8/99; A61K45/06; A61P11/02; A61P11/06; A61P17/00; A61P27/02; A61P27/14; A61P37/08
Foreign References:
| US20180264053A1 | 2018-09-20 | |||
| KR20160053447A | 2016-05-13 | |||
| KR101667496B1 | 2016-10-18 | |||
| KR20180070342A | 2018-06-26 | |||
| KR102185828B1 | 2020-12-03 |
Other References:
MARCO CANDELA ET AL: "Unbalance of intestinal microbiota in atopic children", BMC MICROBIOLOGY, BIOMED CENTRAL LTD., GB, vol. 12, no. 95, 6 June 2012 (2012-06-06), GB , pages 1 - 9, XP021126153, ISSN: 1471-2180, DOI: 10.1186/1471-2180-12-95
See also references of EP 4192484A4
See also references of EP 4192484A4
Attorney, Agent or Firm:
KIM, Hak Je et al. (KR)
Download PDF: